Acadia Pharmaceuticals Inc announced earnings per share of $-0.47 and Sales of $58.31 millions in the forth quarter, Company's decreased loss per share, versus $-0.55 eps, earned in the same quarter a year ago, although Acadia Pharmaceuticals Inc saw it's Sales rise by 599.84 % in the same period.

The nonfarm payrolls grew 304,000 in January, as faster hiring puts more money in the hands of consumers, what usually leads to an increase in spending, as the hiring in the private sector accelerates and the public sector creates new jobs.

Despite soft demand in the forth quarter, company has managed to raise it's earnings per share, profits soared by 39.22 % to $0.72 per share while Sales fell by -3.24 % to $4.62 billions, year on year.

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option.
Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071